Zhang, Zong-Lin <br/><br/>
Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.  [electronic resource] 

 -  Breast cancer (Tokyo, Japan)  Mar 2018 
 - 233-242 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1880-4233 
<br/><br/><label>Standard No.: </label>10.1007/s12282-017-0821-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>Antibiotics, Antineoplastic--pharmacology<br/>Apoptosis--drug effects<br/>Biomarkers, Tumor--genetics<br/>Breast Neoplasms--drug therapy<br/>Cyclooctanes--pharmacology<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Multiple--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Lignans--pharmacology<br/>Phosphorylation<br/>Polycyclic Compounds--pharmacology<br/>STAT3 Transcription Factor--genetics<br/>Signal Transduction--drug effects<br/>Transcription Factor RelA--genetics<br/>Tumor Cells, Cultured